Global Heart Defect Closure Devices Competitive Landscape Professional Research Report 2026 - MarketResearchPoint

MarketResearchPoint

Based on VIC Research’s detailed market assessment, the global Heart Defect Closure Devices market is estimated to reach USD 444.31 Million in 2026 and is forecast to grow to USD 610.75 Million by 2033, registering a CAGR of 4.65% during the 2026–2033 forecast period….
Single: $3300 $3000 Multi: $4300 $4000 Enterprise: $5300 $5000
Pages: 148 Tables: 180

Based on VIC Research’s detailed market assessment, the global Heart Defect Closure Devices market is estimated to reach USD 444.31 Million in 2026 and is forecast to attain USD 610.75 Million by 2033, registering a CAGR of 4.65% during the forecast period (2026–2033). The China Heart Defect Closure Devices market has also experienced notable development in recent years. By 2026, the Chinese market is anticipated to reach Million USD, accounting for approximately % of the global market.

This report delivers an in-depth assessment of the worldwide Heart Defect Closure Devices market, with dedicated coverage of major countries and the Chinese market. It reviews historical performance from 2021 to 2025, considers 2026 as the base year, and presents market forecasts for 2027–2033. The study evaluates sales performance, revenue, pricing, sales volume, gross profit, and market share of leading manufacturers across key regions, while highlighting their latest strategic initiatives. It also examines market segmentation by manufacturer, product type, application, and region, enabling businesses, investors, and new entrants to better understand market demand, growth opportunities, and competitive developments for informed decision-making.

From a regional perspective, the report analyzes North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa, providing insights into market performance and future growth prospects across these regions. It further evaluates regional characteristics by considering industry regulations, economic factors, and technological progress, allowing organizations to strengthen their competitive positioning and refine their global expansion strategies.

The research findings are supported by information collected from multiple reliable sources to ensure analytical accuracy and credibility. Macroeconomic statistics are referenced from national statistical agencies and international research organizations, while industry-specific information is gathered from trade associations. Company-related data is compiled from publicly available resources, interviews, and trusted third-party databases, with pricing information sourced from comprehensive market monitoring systems. The integration and validation of these datasets help ensure objective, reliable, and forward-looking market insights.

The report focuses on the following companies:

Abbott
W.L. Gore
Medtronic Plc.
Boston Scientific Corporation
St. Jude Medical
Biosense Webster
Lifetech Scientific
Starway Medical Technology
Cardia
Occlutech Holding
SentreHEART

Based on product type, the market is segmented into:

Atrial Septal Defect (ASD) Closure Device
Left Atrial Appendage (LAA) Closure Device
Patent Foramen Ovale (PFO) Closure Device
Patent Ductus Arteriosus (PDA) Closure Device
Ventricular Septal Defect (VSD) Closure Device
Others

Based on application, the report covers:

Hospitals
Clinics

Key consumption regions covered in the report include:

US
Europe
China
Japan
Korea
India
Southeast Asia
South America

The report is organized into five major sections covering 10 chapters:

Part One – Foundation (Chapter 1): Introduces the market overview, product definition, key characteristics, product categories, major application areas, and the industrial chain structure of the Heart Defect Closure Devices market.

Part Two – Global Market Analysis (Chapters 2–4): Examines global sales volume, market size, segment-wise performance, and growth forecasts across different product types and application areas.

Part Three – Regional Analysis (Chapters 5–6): Evaluates production, demand, market size, and future growth trends across the major regional markets for Heart Defect Closure Devices.

Part Four – Competitive Landscape (Chapters 7–8): Profiles leading manufacturers, reviewing their products, technologies, applications, market performance, competitive positioning, market share, and industry concentration.

Part Five – Market Outlook (Chapters 9–10): Assesses the industry’s operating environment, emerging opportunities, potential risks, and future growth prospects for the Heart Defect Closure Devices market.

      1. Market Introduction
        1.1 Product Overview, Applications, and Illustrations
        1.2 Global Heart Defect Closure Devices Market Size by Revenue
        1.2.1 Revenue Analysis by Product Type
        1.2.2 Revenue Share by Product Type (%)
        1.3 Global Heart Defect Closure Devices Market by Production Volume
        1.3.1 Production Analysis by Product Type
        1.3.2 Production Share by Product Type (%)

      2. Key Growth Factors of the Heart Defect Closure Devices Industry
        2.1 Historical and Forecast Global Demand Analysis
        2.2 Leading Application Segment (2021–2032)
        2.3 Major Downstream Enterprises in the China Market (2026)

      3. Worldwide and Regional Market Analysis
        3.1 Regional Production and Demand Overview (2026)
        3.2 Regional Revenue Share Analysis (2026–2032)
        3.3 Market Concentration Analysis (CR5 & CR10)
        3.4 Mergers, Acquisitions, and Expansion Activities

      4. United States Heart Defect Closure Devices Market (2021–2032)
        4.1 Production Distribution by Product Type
        4.2 Demand Distribution by Product Type
        4.3 Demand Distribution by Application
        4.4 Revenue Distribution by Product Type (2021–2032)
        4.5 Revenue Distribution by Application (2021–2032)

      5. Europe Heart Defect Closure Devices Market (2021–2032)
        5.1 Production Distribution by Product Type
        5.2 Demand Distribution by Product Type
        5.3 Demand Distribution by Application
        5.4 Revenue Distribution by Product Type (2021–2032)
        5.5 Revenue Distribution by Application (2021–2032)

      6. China Heart Defect Closure Devices Market (2021–2032)
        6.1 Production Distribution by Product Type
        6.2 Demand Distribution by Product Type
        6.3 Demand Distribution by Application
        6.4 Revenue Distribution by Product Type (2021–2032)
        6.5 Revenue Distribution by Application (2021–2032)

      7. Japan Heart Defect Closure Devices Market (2021–2032)
        7.1 Production Distribution by Product Type
        7.2 Demand Distribution by Product Type
        7.3 Demand Distribution by Application
        7.4 Revenue Distribution by Product Type (2021–2032)
        7.5 Revenue Distribution by Application (2021–2032)

      8. India Heart Defect Closure Devices Market (2021–2032)
        8.1 Production Distribution by Product Type
        8.2 Demand Distribution by Product Type
        8.3 Demand Distribution by Application
        8.4 Revenue Distribution by Product Type (2021–2032)
        8.5 Revenue Distribution by Application (2021–2032)

      9. Korea Heart Defect Closure Devices Market (2021–2032)
        9.1 Production Distribution by Product Type
        9.2 Demand Distribution by Product Type
        9.3 Demand Distribution by Application
        9.4 Revenue Distribution by Product Type (2021–2032)
        9.5 Revenue Distribution by Application (2021–2032)

      10. Southeast Asia Heart Defect Closure Devices Market (2021–2032)
        10.1 Production Distribution by Product Type
        10.2 Demand Distribution by Product Type
        10.3 Demand Distribution by Application
        10.4 Revenue Distribution by Product Type (2021–2032)
        10.5 Revenue Distribution by Application (2021–2032)

      11. South America Heart Defect Closure Devices Market (2021–2032)
        11.1 Production Distribution by Product Type
        11.2 Demand Distribution by Product Type
        11.3 Demand Distribution by Application
        11.4 Revenue Distribution by Product Type (2021–2032)
        11.5 Revenue Distribution by Application (2021–2032)

      12. Global Heart Defect Closure Devices Price Analysis
        13.1 Average Price by Product Type in the US (2021–2026)
        13.2 Average Price by Product Type in Europe (2021–2026)
        13.3 Average Price by Product Type in China (2021–2026)
        13.4 Average Price by Product Type in Japan (2021–2026)
        13.5 Average Price by Product Type in India (2021–2026)
        13.6 Average Price by Product Type in Korea (2021–2026)
        13.7 Average Price by Product Type in Southeast Asia (2021–2026)

      13. Industry Value Chain Analysis
        14.1 Heart Defect Closure Devices Industry Chain Overview
        14.2 Downstream Industry Assessment
        14.3 Technological Development Trends

      14. Competitive Analysis
        15.1 Company One
        15.1.1 Abbott Company Profile
        15.1.2 Abbott Product Portfolio
        15.1.3 Abbott Heart Defect Closure Devices Sales and Revenue
        15.1.4 Strategic Developments

      15.2 W.L. Gore
      15.2.1 W.L. Gore Company Profile
      15.2.2 W.L. Gore Product Portfolio
      15.2.3 W.L. Gore Heart Defect Closure Devices Sales and Revenue
      15.2.4 Strategic Developments

      15.3 Medtronic Plc.
      15.3.1 Medtronic Plc. Company Profile
      15.3.2 Medtronic Plc. Product Portfolio
      15.3.3 Medtronic Plc. Heart Defect Closure Devices Sales and Revenue
      15.3.4 Strategic Developments

      15.4 Boston Scientific Corporation
      15.4.1 Boston Scientific Corporation Company Profile
      15.4.2 Boston Scientific Corporation Product Portfolio
      15.4.3 Boston Scientific Corporation Heart Defect Closure Devices Sales and Revenue
      15.4.4 Strategic Developments

      15.5 St. Jude Medical
      15.5.1 St. Jude Medical Company Profile
      15.5.2 St. Jude Medical Product Portfolio
      15.5.3 St. Jude Medical Heart Defect Closure Devices Sales and Revenue
      15.5.4 Strategic Developments

      15.6 Biosense Webster
      15.6.1 Biosense Webster Company Profile
      15.6.2 Biosense Webster Product Portfolio
      15.6.3 Biosense Webster Heart Defect Closure Devices Sales and Revenue
      15.6.4 Strategic Developments

      15.7 Lifetech Scientific
      15.7.1 Lifetech Scientific Company Profile
      15.7.2 Lifetech Scientific Product Portfolio
      15.7.3 Lifetech Scientific Heart Defect Closure Devices Sales and Revenue
      15.7.4 Strategic Developments

      15.8 Starway Medical Technology
      15.8.1 Starway Medical Technology Company Profile
      15.8.2 Starway Medical Technology Product Portfolio
      15.8.3 Starway Medical Technology Heart Defect Closure Devices Sales and Revenue
      15.8.4 Strategic Developments

      15.9 Cardia
      15.10 Occlutech Holding
      15.11 SentreHEART

      1. Summary and Key Findings

      2. Research Methodology

    • Figure 1. Application-wise Demand Analysis of the Heart Defect Closure Devices Market (Volume)
      Figure 2. Regional Production and Demand Overview for Heart Defect Closure Devices (2026)
      Figure 3. Revenue Share Across Major Regions (2026 & 2032)
      Figure 4. Revenue Contribution of Top 10 and Top 5 Market Participants (2026)
      Figure 5. US Heart Defect Closure Devices Market: Production and Demand (2021–2032)
      Figure 6. Production Share by Product Type (%)
      Figure 7. Demand Share by Product Type (%)
      Figure 8. Demand Share by Application (%)
      Figure 9. Revenue Share by Product Type (%)
      Figure 10. Revenue Share by Application (%)
      Figure 11. Europe Heart Defect Closure Devices Market: Production and Demand (2021–2032)
      Figure 12. Production Share by Product Type (%)
      Figure 13. Demand Share by Product Type (%)
      Figure 14. Demand Share by Application (%)
      Figure 15. Revenue Share by Product Type (%)
      Figure 16. Revenue Share by Application (%)
      Figure 17. China Heart Defect Closure Devices Market: Production and Demand (2021–2032)
      Figure 18. Production Share by Product Type (%)
      Figure 19. Demand Share by Product Type (%)
      Figure 20. Demand Share by Application (%)
      Figure 21. Revenue Share by Product Type (%)
      Figure 22. Revenue Share by Application (%)
      Figure 23. Japan Heart Defect Closure Devices Market: Production and Demand (2021–2032)
      Figure 24. Production Share by Product Type (%)
      Figure 25. Demand Share by Product Type (%)
      Figure 26. Demand Share by Application (%)
      Figure 27. Revenue Share by Product Type (%)
      Figure 28. Revenue Share by Application (%)
      Figure 29. India Heart Defect Closure Devices Market: Production and Demand (2021–2032)
      Figure 30. Production Share by Product Type (%)
      Figure 31. Demand Share by Product Type (%)
      Figure 32. Demand Share by Application (%)
      Figure 33. Revenue Share by Product Type (%)
      Figure 34. Revenue Share by Application (%)
      Figure 35. Korea Heart Defect Closure Devices Market: Production and Demand (2021–2032)
      Figure 36. Production Share by Product Type (%)
      Figure 37. Demand Share by Product Type (%)
      Figure 38. Demand Share by Application (%)
      Figure 39. Revenue Share by Product Type (%)
      Figure 40. Revenue Share by Application (%)
      Figure 41. Southeast Asia Heart Defect Closure Devices Market: Production and Demand (2021–2032)
      Figure 42. Production Share by Product Type (%)
      Figure 43. Demand Share by Product Type (%)
      Figure 44. Demand Share by Application (%)
      Figure 45. Revenue Share by Product Type (%)
      Figure 46. Revenue Share by Application (%)
      Figure 47. South America Heart Defect Closure Devices Market: Production and Demand (2021–2032)
      Figure 48. Production Share by Product Type (%)
      Figure 49. Demand Share by Product Type (%)
      Figure 50. Demand Share by Application (%)
      Figure 51. Revenue Share by Product Type (%)
      Figure 52. Revenue Share by Application (%)
      Figure 53. Heart Defect Closure Devices Industry Chain Structure

      Table 1. Leading Manufacturers and Market Classification
      Table 2. Product Overview, Applications, and Illustrations
      Table 3. Revenue of Heart Defect Closure Devices by Product Type (Million USD), 2021–2032
      Table 4. Production of Heart Defect Closure Devices by Product Type, 2021–2032
      Table 5. Application-wise Demand for Heart Defect Closure Devices (2021–2032)
      Table 6. Application-wise Revenue for Heart Defect Closure Devices (Million USD), 2021–2032
      Table 7. Key Downstream Companies in the China Market
      Table 8. Regional Share of Production and Demand (2026)
      Table 9. Regional Revenue Distribution (2026 & 2032)
      Table 10. Global Leading Heart Defect Closure Devices Companies Ranked by Revenue and Market Concentration (2026)
      Table 11. Mergers, Acquisitions, and Business Expansion Activities
      Table 12. US Market Production, Revenue (Million USD), and Demand (2021–2032)
      Table 13. Estimated Production Distribution by Product Type (2021–2032)
      Table 14. Estimated Demand Distribution by Product Type (2021–2032)
      Table 15. Estimated Demand Distribution by Application (2021–2032)
      Table 16. Estimated Revenue Distribution by Product Type
      Table 17. Estimated Revenue Distribution by Application
      Table 18. Europe Market Production, Revenue (Million USD), and Demand (2021–2032)
      Table 19. Estimated Production Distribution by Product Type (2021–2032)
      Table 20. Estimated Demand Distribution by Product Type (2021–2032)
      Table 21. Estimated Demand Distribution by Application (2021–2032)
      Table 22. Estimated Revenue Distribution by Product Type
      Table 23. Estimated Revenue Distribution by Application
      Table 24. China Market Production, Revenue (Million USD), and Demand (2021–2032)
      Table 25. Estimated Production Distribution by Product Type (2021–2032)
      Table 26. Estimated Demand Distribution by Product Type (2021–2032)
      Table 27. Estimated Demand Distribution by Application (2021–2032)
      Table 28. Estimated Revenue Distribution by Product Type
      Table 29. Estimated Revenue Distribution by Application
      Table 30. Japan Market Production, Revenue (Million USD), and Demand (2021–2032)
      Table 31. Estimated Production Distribution by Product Type (2021–2032)
      Table 32. Estimated Demand Distribution by Product Type (2021–2032)
      Table 33. Estimated Demand Distribution by Application (2021–2032)
      Table 34. Estimated Revenue Distribution by Product Type
      Table 35. Estimated Revenue Distribution by Application
      Table 36. India Market Production, Revenue (Million USD), and Demand (2021–2032)
      Table 37. Estimated Production Distribution by Product Type (2021–2032)
      Table 38. Estimated Demand Distribution by Product Type (2021–2032)
      Table 39. Estimated Demand Distribution by Application (2021–2032)
      Table 40. Estimated Revenue Distribution by Product Type
      Table 41. Estimated Revenue Distribution by Application
      Table 42. Korea Market Production, Revenue (Million USD), and Demand (2021–2032)
      Table 43. Estimated Production Distribution by Product Type (2021–2032)
      Table 44. Estimated Demand Distribution by Product Type (2021–2032)
      Table 45. Estimated Demand Distribution by Application (2021–2032)
      Table 46. Estimated Revenue Distribution by Product Type
      Table 47. Estimated Revenue Distribution by Application
      Table 48. Southeast Asia Market Production, Revenue (Million USD), and Demand (2021–2032)
      Table 49. Estimated Production Distribution by Product Type (2021–2032)
      Table 50. Estimated Demand Distribution by Product Type (2021–2032)
      Table 51. Estimated Demand Distribution by Application (2021–2032)
      Table 52. Estimated Revenue Distribution by Product Type
      Table 53. Estimated Revenue Distribution by Application
      Table 54. South America Market Production, Revenue (Million USD), and Demand (2021–2032)
      Table 55. Estimated Production Distribution by Product Type (2021–2032)
      Table 56. Estimated Demand Distribution by Product Type (2021–2032)
      Table 57. Estimated Demand Distribution by Application (2021–2032)
      Table 58. Estimated Revenue Distribution by Product Type
      Table 59. Estimated Revenue Distribution by Application
      Table 60. Average Market Price by Product Type in the US (2021–2026)
      Table 61. Average Market Price by Product Type in Europe (2021–2026)
      Table 62. Average Market Price by Product Type in China (2021–2026)
      Table 63. Average Market Price by Product Type in Japan (2021–2026)
      Table 64. Average Market Price by Product Type in India (2021–2026)
      Table 65. Average Market Price by Product Type in Korea (2021–2026)
      Table 66. Average Market Price by Product Type in Southeast Asia (2021–2026)
      Table 67. Major Downstream Customers by Application Segment
      Table 68. Abbott Company Profile
      Table 69. Abbott Product Portfolio
      Table 70. Abbott Heart Defect Closure Devices Sales (Units) and Revenue (Million USD), 2021–2026
      Table 71. W.L. Gore Company Profile
      Table 72. W.L. Gore Product Portfolio
      Table 73. W.L. Gore Heart Defect Closure Devices Sales (Units) and Revenue (Million USD), 2021–2026
      Table 74. Medtronic Plc. Company Profile
      Table 75. Medtronic Plc. Product Portfolio
      Table 76. Medtronic Plc. Heart Defect Closure Devices Sales (Units) and Revenue (Million USD), 2021–2026
      Table 77. Boston Scientific Corporation Company Profile
      Table 78. Boston Scientific Corporation Product Portfolio
      Table 79. Boston Scientific Corporation Heart Defect Closure Devices Sales (Units), Revenue (Million USD), and Price (2021–2026)
      Table 83. Biosense Webster Company Profile
      Table 84. Biosense Webster Product Portfolio
      Table 85. Biosense Webster Heart Defect Closure Devices Sales (Units) and Revenue (Million USD), 2021–2026
      Table 86. Lifetech Scientific Company Profile
      Table 87. Lifetech Scientific Product Portfolio
      Table 88. Lifetech Scientific Heart Defect Closure Devices Sales (Units) and Revenue (Million USD), 2021–2026
      Table 89. Starway Medical Technology Company Profile
      Table 90. Starway Medical Technology Product Portfolio
      Table 91. Starway Medical Technology Heart Defect Closure Devices Sales (Units) and Revenue (Million USD), 2021–2026

  1. VICResearch follows a well-structured research methodology designed to ensure the reliability, consistency, and accuracy of every report. All analysts are full-time professionals who undergo more than six months of specialized training to meet the company’s quality standards. The overall research process is organized into five key stages.

    Stage 1: Secondary research

    The research process begins with an extensive review of industry publications, trade associations, government sources, and other relevant databases. Information gathered through VICResearch’s in-house documentation resources provides the foundation for further analysis. Experienced analysts carefully evaluate and extract the most relevant and dependable market information from these existing sources.

    Stage 2: Primary research: interviews with trade sources

    Following the secondary research phase, analysts conduct extensive telephone and face-to-face interviews with industry participants. Discussions include leading companies as well as smaller market players, along with suppliers, manufacturers, distributors, importers, installers, wholesalers, and end users. The findings obtained through these interviews are carefully verified against secondary research to improve data accuracy.

    Stage 3: Analysis of the gathered data

    The collected information is thoroughly reviewed, validated, and consolidated by the research team. Whenever necessary, additional interviews are conducted to confirm findings and strengthen the accuracy of the final analysis.

    Stage 4: Quantitative data

    VICResearch develops quantitative insights covering market size, production capacity, manufacturer output, market forecasts, and investment feasibility based on the validated findings from the previous stages. The research team also provides detailed market interpretation and analytical insights, ensuring that the quantitative data presented in each report is unique and highly reliable.

    Stage 5: Quality control

    Before publication, every report undergoes a comprehensive review and editing process conducted by an experienced management team to maintain the highest quality standards. In addition, analysts receive continuous guidance and ongoing professional training as part of VICResearch’s internal quality assurance program.

Scroll to Top